Cordis Corporation Receives CE Mark for RENLANEâ„¢ Renal Denervation System to Treat Resistant Hypertension

[Business Wire] – Cordis Corporation announced today that it has received European CE Mark for its RENLANEâ„¢ Renal Denervation System for the treatment of patients with resistant hypertension and has completed the first successful cases in Europe. more

View todays social media effects on JNJ

View the latest stocks trending across Twitter. Click to view dashboard

See who Johnson is hiring next, click here to view